Home › Carcinoma in Situ
Carcinoma in Situ clinical trials recruiting in the U.S.
8 studies for Carcinoma in Situ are recruiting participants at sites across the United States.
Cities with the most studies
- Little Rock, AR4 studies
- Austin, TX4 studies
- Boston, MA4 studies
- Houston, TX4 studies
- Pittsburgh, PA3 studies
- New York City, NY3 studies
- Portland, OR3 studies
- Jacksonville, FL3 studies
- Philadelphia, PA3 studies
- Rochester, MN3 studies
- Syracuse, NY3 studies
- Birmingham, AL3 studies
- Atlanta, GA3 studies
- St. Louis, MO3 studies
- Cincinnati, OH3 studies
- Los Angeles, CA3 studies
- Memphis, TN3 studies
- Nashville, TN3 studies
- Bakersfield, CA3 studies
- Myrtle Beach, SC3 studies
By state
- Alabama3 studies
- Arizona4 studies
- Arkansas4 studies
- California5 studies
- Colorado4 studies
- Florida4 studies
- Georgia3 studies
- Illinois3 studies
- Louisiana3 studies
- Massachusetts4 studies
- Minnesota3 studies
- Missouri4 studies
- New York4 studies
- Ohio4 studies
- Oregon3 studies
- Pennsylvania5 studies
- South Carolina4 studies
- Tennessee4 studies
- Texas5 studies
- Virginia4 studies
- Washington3 studies
Recently updated studies
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06833073Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07480356InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 17, 2026 · NCT05463796LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Apr 17, 2026 · NCT07322263EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Recruiting
Ages 20 to 89 · Women · Updated Feb 4, 2026 · NCT06115486From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.